A detailed history of Greenland Capital Management LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Greenland Capital Management LP holds 24,224 shares of ITCI stock, worth $3.19 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
24,224
Holding current value
$3.19 Million
% of portfolio
0.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$81.78 - $131.92 $1.98 Million - $3.2 Million
24,224 New
24,224 $3.2 Billion

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.4B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Greenland Capital Management LP Portfolio

Follow Greenland Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenland Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Greenland Capital Management LP with notifications on news.